Overview
Samer Ibrahim is a Hematologist and an Oncologist in Burlington, Massachusetts. Dr. Ibrahim is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
41 Mall Rd, Lahey Provider Enrollment Dept, Burlington, MA 01805
1 Essex Ctr Dr, Peabody, MA 01960
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Irene Ghobrial is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Ghobrial is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Ghobrial is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Omar Nadeem is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Nadeem is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nadeem is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Elizabeth O'donnell is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. O'donnell is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Orchiectomy, and Bone Marrow Aspiration. Dr. O'donnell is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerDr. Ibrahim isExperienced. Learn about Lung Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Non-Small Cell Lung Cancer (NSCLC)Dr. Ibrahim isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Schnitzler SyndromeDr. Ibrahim isExperienced. Learn about Schnitzler Syndrome.